BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17982047)

  • 1. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
    Kim JH; Choi EY; Chung DH
    J Immunol; 2007 Nov; 179(10):6579-87. PubMed ID: 17982047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells.
    Hashimoto D; Asakura S; Miyake S; Yamamura T; Van Kaer L; Liu C; Tanimoto M; Teshima T
    J Immunol; 2005 Jan; 174(1):551-6. PubMed ID: 15611282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
    Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
    J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells.
    Lan F; Zeng D; Higuchi M; Higgins JP; Strober S
    Biol Blood Marrow Transplant; 2003 Jun; 9(6):355-63. PubMed ID: 12813443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
    J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
    Chen YT; Kung JT
    J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure.
    Ragin MJ; Sahu N; August A
    Infect Immun; 2006 Jan; 74(1):282-8. PubMed ID: 16368982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe graft-versus-host disease in SCID mice is associated with a decrease of selective donor cell TCR Vbeta specificities and increased expression of IFN-gamma and IL-4.
    Schneider MK; Ekholm F; Grönvik KO
    Scand J Immunol; 1997 Aug; 46(2):147-58. PubMed ID: 9583995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells.
    Foley JE; Mariotti J; Ryan K; Eckhaus M; Fowler DH
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):959-972. PubMed ID: 18721759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex.
    Hansen DS; Siomos MA; Buckingham L; Scalzo AA; Schofield L
    Immunity; 2003 Mar; 18(3):391-402. PubMed ID: 12648456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
    Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice.
    Rogers L; Burchat S; Gage J; Hasu M; Thabet M; Willcox L; Ramsamy TA; Whitman SC
    Cardiovasc Res; 2008 Apr; 78(1):167-74. PubMed ID: 18192239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.
    Wahl C; Bochtler P; Schirmbeck R; Reimann J
    J Immunol; 2007 Feb; 178(4):2083-93. PubMed ID: 17277112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.
    Zeng D; Lewis D; Dejbakhsh-Jones S; Lan F; García-Ojeda M; Sibley R; Strober S
    J Exp Med; 1999 Apr; 189(7):1073-81. PubMed ID: 10190898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The regulatory role of V alpha 14 NKT cells in innate and acquired immune response].
    Harada M; Taniguchi M
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2109-16. PubMed ID: 12518422
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of type II NKT cells in the suppression of graft-versus-host disease.
    Oh SJ; Kim JH; Min CK; Chung DH
    Crit Rev Immunol; 2008; 28(3):249-67. PubMed ID: 19024348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
    Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
    Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival.
    Shaulov A; Yue S; Wang R; Joyce RM; Balk SP; Kim HT; Avigan DE; Uhl L; Sackstein R; Exley MA
    Exp Hematol; 2008 Apr; 36(4):464-72. PubMed ID: 18261838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.